# Immune Responses to Pneumococcal Vaccination Among HIV-infected Subjects

> **NCT00706550** · NA · COMPLETED · sponsor: **US Department of Veterans Affairs** · enrollment: 107 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **BIOLOGICAL:** (PV) 23-valent pneumococcal polysaccharide vaccine
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT00706550
- **Lead sponsor:** US Department of Veterans Affairs
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2011-09
- **Final completion:** 2012-09
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2014-04-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00706550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00706550, "Immune Responses to Pneumococcal Vaccination Among HIV-infected Subjects". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00706550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*